These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8056700)

  • 41. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children.
    McKamy S; Hernandez E; Jahng M; Moriwaki T; Deveikis A; Le J
    J Pediatr; 2011 Mar; 158(3):422-6. PubMed ID: 20888013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.
    Hanrahan TP; Harlow G; Hutchinson J; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA
    Crit Care Med; 2014 Dec; 42(12):2527-36. PubMed ID: 25083977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for amphotericin B-induced nephrotoxicity.
    Luber AD; Maa L; Lam M; Guglielmo BJ
    J Antimicrob Chemother; 1999 Feb; 43(2):267-71. PubMed ID: 11252333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nephrotoxicity comparison of two commercially available generic vancomycin products.
    Sutton JD; Mynatt RP; Kaye KS; Murray KP; Rybak MJ; Pogue JM
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5470-4. PubMed ID: 26124161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of an Antimicrobial Stewardship Program on Patient Safety in Veterans Prescribed Vancomycin.
    Fodero KE; Horey AL; Krajewski MP; Ruh CA; Sellick JA; Mergenhagen KA
    Clin Ther; 2016 Mar; 38(3):494-502. PubMed ID: 26831569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vancomycin nephrotoxicity: a review.
    Mergenhagen KA; Borton AR
    J Pharm Pract; 2014 Dec; 27(6):545-53. PubMed ID: 25266809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High Single-dose Vancomycin Loading Is Not Associated With Increased Nephrotoxicity in Emergency Department Sepsis Patients.
    Rosini JM; Davis JJ; Muenzer J; Levine BJ; Papas MA; Comer D; Arnold R
    Acad Emerg Med; 2016 Jun; 23(6):744-6. PubMed ID: 26850378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vancomycin-associated renal dysfunction: where are we now?
    Carreno JJ; Kenney RM; Lomaestro B
    Pharmacotherapy; 2014 Dec; 34(12):1259-68. PubMed ID: 25220436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity.
    Rostas SE; Kubiak DW; Calderwood MS
    Clin Ther; 2014 Jul; 36(7):1098-101. PubMed ID: 24931573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies.
    Fernández de Gatta MD; Calvo MV; Hernández JM; Caballero D; San Miguel JF; Domínguez-Gil A
    Clin Pharmacol Ther; 1996 Sep; 60(3):332-40. PubMed ID: 8841156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy.
    Ingram PR; Lye DC; Fisher DA; Goh WP; Tam VH
    Int J Antimicrob Agents; 2009 Dec; 34(6):570-4. PubMed ID: 19744837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Evaluation of the Incidence of Nephrotoxicity After a Loading Dose of Vancomycin in Patients With Severe Renal Impairment.
    Marvin JL; Levine BJ; Papas M; Rosini JM
    J Emerg Med; 2019 Jun; 56(6):701-708. PubMed ID: 31029400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity when Used with Vancomycin: A Meta-Analysis of Observational Trials.
    Mellen CK; Ryba JE; Rindone JP
    Curr Drug Saf; 2017; 12(1):62-66. PubMed ID: 27784223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nephrotoxicity of vancomycin in patients with normal serum creatinine.
    Colares VS; Oliveira RB; Abdulkader RC
    Nephrol Dial Transplant; 2006 Dec; 21(12):3608. PubMed ID: 16861241
    [No Abstract]   [Full Text] [Related]  

  • 55. Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients.
    Malacarne P; Bergamasco S; Donadio C
    Chemotherapy; 2006; 52(4):178-84. PubMed ID: 16691027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Whole Price of Vancomycin: Toxicities, Troughs, and Time.
    Jeffres MN
    Drugs; 2017 Jul; 77(11):1143-1154. PubMed ID: 28573434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods.
    Stewart DJ; Dulberg CS; Mikhael NZ; Redmond MD; Montpetit VA; Goel R
    Cancer Chemother Pharmacol; 1997; 40(4):293-308. PubMed ID: 9225947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vancomycin-Associated Nephrotoxicity: The Obesity Factor.
    Davies SW; Efird JT; Guidry CA; Dietch ZC; Willis RN; Shah PM; Hennessy SA; Sawyer RG
    Surg Infect (Larchmt); 2015 Dec; 16(6):684-93. PubMed ID: 26324996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates.
    Constance JE; Balch AH; Stockmann C; Linakis MW; Korgenski EK; Roberts JK; Ward RM; Sherwin CM; Spigarelli MG
    Arch Dis Child Fetal Neonatal Ed; 2016 May; 101(3):F236-43. PubMed ID: 26400103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative Incidence of Nephrotoxicity by Age Group among Adult Patients Receiving Vancomycin.
    Carreno JJ; Jaworski A; Kenney RM; Davis SL
    Infect Dis Ther; 2013 Dec; 2(2):201-8. PubMed ID: 25134482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.